Lineage Infidelity of MDA-MB-435 Cells
暂无分享,去创建一个
Gordon B Mills | Dihua Yu | G. Mills | Dihua Yu | Wentao Yang | Xiaoyan Zhou | Shankar Sellappan | Rebecca Grijalva | Xiaoyan Zhou | Wentao Yang | Menashe Bar Eli | S. Sellappan | R. Grijalva | M. B. Eli
[1] A. Hamburger,et al. Regulation of heregulinβ1‐induced differentiation in a human breast carcinoma cell line by the extracellular‐regulated kinase (ERK) pathway , 1998, Journal of cellular biochemistry.
[2] M. Gonda,et al. Production of recombinant MART-1 proteins and specific antiMART-1 polyclonal and monoclonal antibodies: use in the characterization of the human melanoma antigen MART-1. , 1997, Journal of immunological methods.
[3] S. Bacus,et al. Differentiation of cultured human breast cancer cells (AU‐565 and MCF‐7) associated with loss of cell surface HER‐2/neu antigen , 1990, Molecular carcinogenesis.
[4] J. Bartek,et al. Production and Characterization of Monoclonal Antibodies to Human Casein. A Monoclonal Antibody That Cross-Reacts With Casein and α-Lactalbumin , 1985 .
[5] Dihua Yu,et al. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities. , 1997, Cancer research.
[6] I. Fidler,et al. Relative malignant potential of human breast carcinoma cell lines established from pleural effusions and a brain metastasis. , 1991, Invasion & metastasis.
[7] Christian A. Rees,et al. Systematic variation in gene expression patterns in human cancer cell lines , 2000, Nature Genetics.
[8] G. Ellison,et al. Further evidence to support the melanocytic origin of MDA-MB-435 , 2002, Molecular pathology : MP.
[9] Wolfgang Henrich,et al. The prognostic significance of epithelial-mesenchymal transition in breast cancer. , 2002, Anticancer research.
[10] A. Patchefsky,et al. Primary combined malignant melanoma and ductal carcinoma of the breast: A report of two cases , 1996, Cancer.
[11] C. Gillett,et al. A comparative immunohistochemical study of mammary and extramammary Paget's disease and superficial spreading melanoma, with particular emphasis on melanocytic markers , 1996, Virchows Archiv.
[12] K. Prasad,et al. Effects of tocopherol (vitamin E) acid succinate on morphological alterations and growth inhibition in melanoma cells in culture. , 1982, Cancer research.
[13] Jun Yao,et al. Overexpression of ErbB2 blocks Taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinase. , 1998, Molecular cell.
[14] P. Chu,et al. Keratin expression in human tissues and neoplasms , 2002, Histopathology.
[15] T. Powles,et al. Prediction of clinical outcome from primary tamoxifen by expression of biologic markers in breast cancer patients. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[16] L. Leder,et al. Lineage infidelity in chronic myeloid leukemia , 1986, Virchows Archiv. B, Cell pathology including molecular pathology.
[17] N. Ohuchi,et al. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer. , 2001, International journal of oncology.
[18] P. Brown,et al. Role of extracellular signal–regulated kinase pathway in RRR‐α‐tocopheryl succinate–induced differentiation of human MDA‐MB‐435 breast cancer cells , 2002, Molecular carcinogenesis.
[19] S. Futagawa,et al. Breast carcinoma diverging to aberrant melanocytic differentiation: a case report with histopathologic and loss of heterozygosity analyses. , 1999, The American journal of surgical pathology.
[20] Omgo E. Nieweg,et al. Frozen Section Investigation of the Sentinel Node in Malignant Melanoma and Breast Cancer , 2001, Annals of Surgical Oncology.
[21] M. Pasdar,et al. The importance of MUC1 cellular localization in patients with breast carcinoma , 2001, Cancer.
[22] M. Hendrix,et al. Molecular biology of breast cancer metastasis Molecular expression of vascular markers by aggressive breast cancer cells , 2000, Breast Cancer Research.
[23] J. Klostergaard,et al. Cytotoxic effects of sphingolipids as single or multi-modality agents on human melanoma and soft tissue sarcoma in vitro , 1998, Melanoma research.
[24] C. Bucana,et al. Correlation of growth capacity of human tumor cells in hard agarose with their in vivo proliferative capacity at specific metastatic sites. , 1989, Journal of the National Cancer Institute.
[25] B. Brinkley,et al. Variations in cell form and cytoskeleton in human breast carcinoma cells in vitro. , 1980, Cancer research.
[26] J. Lakins,et al. Expression and regulation of estrogen receptor beta in human breast tumors and cell lines. , 2000, Oncology reports.
[27] Dihua Yu,et al. ErbB2 overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human breast carcinoma , 2002, Cancer.
[28] Y. Katagata,et al. Keratin expression and its significance in five cultured melanoma cell lines derived from primary, recurrent and metastasized melanomas , 1997, FEBS letters.
[29] M. Hung,et al. Phosphorylation on tyrosine-15 of p34(Cdc2) by ErbB2 inhibits p34(Cdc2) activation and is involved in resistance to taxol-induced apoptosis. , 2002, Molecular cell.
[30] C. Clavel,et al. Quantitative cell dispersion analysis: New test to measure tumor cell aggressiveness , 2001, International journal of cancer.
[31] S. Lakhani,et al. Proliferation and differentiation in the human breast during pregnancy. , 2000, Differentiation; research in biological diversity.
[32] J. Sloane,et al. Distribution of epithelial membrane antigen in normal and neoplastic tissues and its value in diagnostic tumor pathology , 1981, Cancer.
[33] G. V. Vande Woude,et al. Met-HGF/SF mediates growth arrest and differentiation in T47D breast cancer cells. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[34] F. Oesch,et al. Inverse relationship of melanocyte differentiation antigen expression in melanoma tissues and CD8+ cytotoxic‐T‐cell responses: Evidence for immunoselection of antigen‐loss variants in vivo , 1996, International journal of cancer.
[35] M. Hendrix,et al. Biologic determinants of uveal melanoma metastatic phenotype: role of intermediate filaments as predictive markers. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[36] N. Ohuchi,et al. The loss of E-cadherin, α- and β-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer , 2001 .
[37] M. Hung,et al. Suppressed transformation and induced differentiation of HER-2/neu-overexpressing breast cancer cells by emodin. , 1995, Cancer research.
[38] Dihua Yu,et al. Combined trastuzumab and paclitaxel treatment better inhibits ErbB‐2‐mediated angiogenesis in breast carcinoma through a more effective inhibition of Akt than either treatment alone , 2003, Cancer.
[39] M. Lotem,et al. Expression of tyrosinase, MIA and MART‐1 in sentinel lymph nodes of patients with malignant melanoma , 2002, The British journal of dermatology.
[40] W. Yu,et al. RRR-alpha-tocopheryl succinate induces MDA-MB-435 and MCF-7 human breast cancer cells to undergo differentiation. , 2001, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[41] D. Fisher,et al. Age-resolving Osteopetrosis: A Rat Model Implicating Microphthalmia and the Related Transcription Factor TFE3 , 1998, The Journal of experimental medicine.
[42] I. Schmidt-Wolf,et al. Coexpression of lymphoid and myeloid markers on cell surfaces. , 1997, Leukemia & lymphoma.
[43] D. Taverna,et al. NDF/heregulin activates MAP kinase and p70/p85 S6 kinase during proliferation or differentiation of mammary epithelial cells. , 1995, Oncogene.
[44] G. Hortobagyi,et al. Enhanced sensitization to taxol-induced apoptosis by herceptin pretreatment in ErbB2-overexpressing breast cancer cells. , 2002, Cancer research.
[45] E. Scanziani,et al. Comparative study on the metastatic behavior of human tumors in nude, beige/nude/xid and severe combined immunodeficient mice. , 1993, Invasion & metastasis.